Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Lilly, Dana-Farber Cancer Institute Announce Research Collaboration

June 18, 2015 8:59 am | News | Comments

Eli Lilly and Company and Dana-Farber Cancer Institute announced a multiyear collaboration to research new medicines under development to fight cancer. Read more...

TOPICS:

New EU Post-Marketing Study Requirements for Vaccines: An Update

June 18, 2015 8:58 am | by Priscilla Velentgas, senior director of epidemiology, Quintiles Real-World and Late Phase Research; Ombretta Palucci, senior director, Real-World Evidence Strategy Unit, Quintiles Real-World and Late Phase Research | Articles | Comments

Under new draft guidance from the EMA, post-marketing studies of safety and effectiveness are required to be launched for seasonal influenza vaccines shortly after the beginning of the vaccination campaign each year. Based on this guidance, biopharma companies must take into account various operational, statistical and epidemiological elements in the planning of annual enhanced safety surveillance efforts. Read more...

TOPICS:

DDT’s Health Effects Continue to Ripple, with New Breast Cancer Link

June 17, 2015 1:44 pm | by Seth Augenstein, Digital Reporter | News | Comments

DDT was a wonder pesticide, which turned the tide on everything from bed bugs to malaria-carrying mosquitoes during the 20th century. But even after its health and environmental effects were acknowledged and its agricultural use was banned in 1972, its toxic legacy continues, according to a new study. Read more...

TOPICS:
Advertisement

Kezar Life Sciences Closes $23M Series A Financing

June 17, 2015 1:39 pm | News | Comments

Kezar Life Sciences, a company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders, announced the completion of a Series A financing totaling $23 million. Read more...

TOPICS:

Seeking Rare Cells

June 17, 2015 1:33 pm | by MIT | News | Comments

Christopher Love uses microscale technology to isolate rare cells, yielding insight into human disease. Read more...

TOPICS:

Johns Hopkins University, Bayer to Develop New Ophthalmic Therapies

June 17, 2015 1:03 pm | by Johns Hopkins University | News | Comments

The Johns Hopkins University and Bayer HealthCare have entered into a five-year collaboration agreement to jointly develop new ophthalmic therapies targeting retinal diseases. The goal of the strategic research alliance is to accelerate the translation of innovative approaches from the laboratory to the clinic, ultimately offering patients new treatment options for several retinal diseases. Read more...

TOPICS:

Bert Vogelstein, M.D., Wins 2015 Dr. Paul Janssen Award for Biomedical Research

June 17, 2015 12:58 pm | News | Comments

Johnson & Johnson today named Dr. Bert Vogelstein of Johns Hopkins University, Johns Hopkins Kimmel Cancer Center and the Howard Hughes Medical Institute, the winner of the 2015 Dr. Paul Janssen Award for Biomedical Research for his breakthroughs in oncology research, which have spanned more than two decades and have formed the basis of modern cancer research. Read more...

TOPICS:

Complex, Large-scale Genome Analysis Made Easier

June 17, 2015 12:51 pm | by European Molecular Biology Laboratory | News | Comments

Researchers at EMBL-EBI have developed a new approach to studying the effect of multiple genetic variations on different traits. The new algorithm,published in Nature Methods, makes it possible to perform genetic analysis of up to 500,000 individuals — and many traits at the same time. Read more...

TOPICS:
Advertisement

The Rise of Syngeneic Models in Cancer Immunotherapy

June 17, 2015 10:06 am | by Sheri Barnes, Ph.D., Study Director, Charles River | Articles | Comments

With cancer immunotherapy a major focus of oncology research over the past several years, a blockbuster drug will likely target the immune system. The industry is responding in kind by developing new tools that can be employed in this rapidly expanding field. One tool oncology researchers are exploring is actually not new at all—the murine tumor model. Read more...

TOPICS:

'Core' Immune Cells Reduce Symptoms, Spread of Seasonal and Pandemic Influenza

June 17, 2015 9:16 am | by University of Oxford | News | Comments

Influenza A is the most common type of influenza and is the only type that can cause pandemics. Read more...

TOPICS:

Big Shareholder Backs Drugmaker Mylan's Growth Strategy

June 17, 2015 9:08 am | by The Associated Press | News | Comments

Mylan's largest shareholder has backed the generic drugmaker's plan to remain a stand-alone company as it fights a takeover bid from larger rival Teva Pharmaceutical. Read more...

TOPICS:

Allergan to Acquire Kythera Biopharmaceuticals

June 17, 2015 8:53 am | News | Comments

This purchase compliments Allergan's existing position in facial aesthetics. Read more...

TOPICS:

Richter, Allergan Announce FDA Extended Review Period for Cariprazine to September 2015

June 17, 2015 8:47 am | News | Comments

Cariprazine is being reviewed for the treatment of schizophrenia and for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Read more...

TOPICS:

UN: Spread of MERS in South Korea Isn't Global Emergency

June 17, 2015 8:42 am | by Maria Cheng, AP Medical Writer | News | Comments

WHO acknowledged there were still fundamental gaps in its understanding of the disease nearly three years after MERS was first identified. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading